Wire Stories

Category Added in a WPeMatico Campaign

Horizon_Logo_Full-Color_RGB_Registered_Logo

Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in Japan Evaluating TEPEZZA® (teprotumumab-trbw) in Adults with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED)